The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

Journal of Virology

Volumn 76, Issue 17, 2002, Pages 8953-8957

  Cormier, Emmanuel G ^a   Dragic, Tatjana ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; PEPTIDE; VIRUS ENVELOPE PROTEIN;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; VIRION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE; GENE DELETION; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES; RECEPTORS, CCR5; RECOMBINANT FUSION PROTEINS; SULFUR; TRANSFECTION;

EID: 0036333648     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.17.8953-8957.2002     Document Type: Article

References (31)

1. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
2. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
3. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity
4. Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages)
5. Local and global structural properties of the HIV-MN V3 loop
6. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
7. An overview of HIV-1 coreceptor function and its inhibitors
8. Specific interaction of CCR5 amino-terminal domain peptides containing sulfo-tyrosines with HIV-1 envelope glycoprotein gp120
9. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes
10. An overview of the determinants of CCR5 and CXCR4 co-receptor function
11. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry
12. A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
13. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry
14. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100
15. HIV-1 envelope determinants for cell tropism and chemokine receptor use
16. Identification of Env determinants in V3 that influence the molecular anatomy of CCR5 utilization
17. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates
18. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
19. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function
20. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
21. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
22. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region
23. gp120: Biologic aspects of structural features
24. The second extracellular loop of CXCR4 is involved in CD4-independent entry of human immunodeficiency virus type 2
25. Crystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigen
26. Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits
27. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein
28. CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates
29. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding
30. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage
31. The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus